Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple

Wen-Xin Huang1, Ping Huang, Jan Hillert

  • 1Division of Neurology, Karolinska Institute, Huddinge University Hospital, Huddinge, Sweden.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|October 9, 2004
PubMed

Insights

This study found increased levels of caspase-1 and interleukin-18 (IL-18) in multiple sclerosis (MS) patients, suggesting a potential role for these molecules in MS pathogenesis and future therapies.

Area of Science:

  • Neuroimmunology
  • Immunology
  • Molecular Biology

Background:

  • Multiple sclerosis (MS) is an autoimmune disorder affecting the central nervous system, with T-cells and apoptosis-regulating molecules implicated in its pathogenesis.
  • The role of specific cytokines, such as interleukin-18 (IL-18) and interleukin-1beta (IL-1beta), and their processing enzyme caspase-1 in MS is not fully elucidated.

Purpose of the Study:

  • To quantify the mRNA and protein expression levels of IL-18, IL-1beta, and caspase-1 in peripheral blood mononuclear cells (PBMCs) of untreated multiple sclerosis patients.
  • To investigate the correlation between the expression of these molecules and different clinical subtypes of MS.

Main Methods:

  • Competitive reverse transcription-polymerase chain reaction (RT-PCR) was used to measure mRNA levels of IL-18, IL-1beta, and caspase-1.
  • Western blot analysis was employed to validate protein expression patterns.
  • Peripheral blood mononuclear cells (PBMCs) were analyzed from patients with multiple sclerosis and healthy controls.

Main Results:

  • Significantly increased mRNA expression of caspase-1 and IL-18 was observed in multiple sclerosis patients compared to healthy controls.
  • Caspase-1 expression was elevated across all MS clinical subgroups.
  • IL-18 was upregulated in chronic progressive MS and relapsing MS patients in remission, but not during relapses.
  • IL-1beta mRNA levels showed no significant alteration, with a possible decrease in chronic progression.

Conclusions:

  • Elevated expression of caspase-1 and IL-18 suggests their involvement in the pathogenesis of multiple sclerosis.
  • The increased IL-18 expression, potentially at the protein level, highlights a promising pathway for future therapeutic strategies in MS.
  • Further research into the role of IL-18 and caspase-1 could lead to novel treatment approaches for multiple sclerosis.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...